Nalaganje...

Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Uncontrolled Oncology Trials: A Comprehensive Review of the Literature

Several drugs gained market authorization based on the demonstration of improved progression-free survival (PFS), adopted as a primary endpoint in Phase 3 clinical trials. In addition, an increasing number of drugs have been granted accelerated approval, and sometimes regular approval, by the main r...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Cinzia Dello Russo, Pierluigi Navarra
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2022-05-01
Serija:Frontiers in Pharmacology
Teme:
ORR
PFS
Online dostop:https://www.frontiersin.org/articles/10.3389/fphar.2022.858354/full
Oznake: Označite
Brez oznak, prvi označite!